泰林生物 (300813.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

CNY 2.47B

MomentumView details →

1D Return

−3.60%

YTD Return

−16.36%

RSI (14)

50.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

CNY 2.47B

RSI (14)

50.9

MomentumView details →

1D Return

−3.60%

YTD Return

−16.36%

ProfitabilityView details →

Gross Margin

45.69%

Net Margin

5.19%

EBITDA Margin

11.02%

ROE (TTM)

2.21%

ROA (TTM)

1.88%

Asset Turnover

0.36x

GrowthView details →

Revenue YoY

+2.00%

EPS YoY

+54.83%

FCF YoY

−97.48%

Revenue CAGR 3Y

−3.16%

EPS CAGR 3Y

−42.59%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

4.00x

Quick Ratio

3.04x

Div Yield

0.63%

Div Rate

CNY 0.13

Div Growth 1Y

−85.00%

Financials snapshotView financials →

Revenue (TTM)

342.66M

Net Income (TTM)

17.80M

Op. CF (TTM)

54.90M

Latest newsMore news →

Talin Bio terminated its application to issue convertible bonds to unspecified investors and withdrew the application with the Shenzhen Stock Exchange on August 21, 2026.12d ago

Similar companies

好利科技002729.SZ 腾亚精工301125.SZ 国创高新002377.SZ 汇源通信000586.SZ 捷荣技术002855.SZ 日月明300906.SZ Find similar companies →

Latest newsMore news →

Talin Bio terminated its application to issue convertible bonds to unspecified investors and withdrew the application with the Shenzhen Stock Exchange on August 21, 2026.12d ago